
Performance of PCA3 and TMPRSS2:ERG Within the Prostate Cancer Prevention Trial Risk Calculator Version 2 in a ...
Introduction Prostate cancer (PCa) is the second most commonly diagnosed cancer after lung cancer and the sixth leading cause of cancer-related deaths among men worldwide.1 Early detection is crucial, yet PSA-based screening has low specificity (20–30%), …